🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Status
Terminated
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Start Date
2022-12-07
Trial ID
NCT04915404
Treatments Being Tested
To determine the toxicities, maximum tolerated dose (MTD) and recommended p...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2006-10
Trial ID
NCT00408226
Treatments Being Tested
The objective of this study is to evaluate the safety, tolerability and pha...
Status
Completed
Location
Site JP00001
Start Date
2017-11-14
Trial ID
NCT03361540
The purpose of this study is to investigate the effectiveness of a dual-tar...
Status
Not Yet Recruiting
Location
Anhui Medical University
Start Date
2026-03-01
Trial ID
NCT07403591
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
The purpose of this research study is to find the lowest dose of the cancer...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-06-01
Trial ID
NCT04142554
Treatments Being Tested
Based on data supporting the use of cyclophosphamide and etoposide both as ...
Status
Completed
Location
Central Jersey Oncology Center
Start Date
2005-05
Trial ID
NCT00176605
Treatments Being Tested
This Phase II study is conducted to assess the safety and efficacy of CPI-6...
Status
Withdrawn
Location
Eastchester Center for Cancer Care
Start Date
2014-01
Trial ID
NCT01830322
Treatments Being Tested
The overall objective of this study is to preliminarily evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07715097
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859